BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Federal Trade Commission
Fuji
Chinese Patent Office
AstraZeneca
US Department of Justice
Healthtrust
Chubb
Express Scripts
Cipla

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077966

« Back to Dashboard

NDA 077966 describes MILRINONE LACTATE, which is a drug marketed by Baxter Hlthcare Corp, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma Farmaceutica, Hospira, Hospira Inc, Intl Medicated, Mylan Institutional, West-ward Pharms Int, Renaissance Ssa Llc, B Braun, and Baxter Hlthcare, and is included in twenty NDAs. It is available from five suppliers. Additional details are available on the MILRINONE LACTATE profile page.

The generic ingredient in MILRINONE LACTATE is milrinone lactate. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the milrinone lactate profile page.
Summary for 077966
Tradename:MILRINONE LACTATE
Applicant:Hikma Farmaceutica
Ingredient:milrinone lactate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 077966
Suppliers and Packaging for NDA: 077966
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MILRINONE LACTATE milrinone lactate INJECTABLE;INJECTION 077966 ANDA West-ward Pharmaceutical Corp 0143-9708 0143-9708-10 10 VIAL in 1 BOX (0143-9708-10) > 50 mL in 1 VIAL (0143-9708-01)
MILRINONE LACTATE milrinone lactate INJECTABLE;INJECTION 077966 ANDA West-ward Pharmaceutical Corp 0143-9709 0143-9709-10 20 mL in 1 VIAL (0143-9709-10)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 1MG BASE/ML
Approval Date:Dec 3, 2010TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Medtronic
Cerilliant
Argus Health
AstraZeneca
Julphar
Chubb
US Department of Justice
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot